Merck Press Releases

Published on July 14, 2013 - 12:34 GMT

Merck Presents Findings from Phase 1b Study of Investigational BACE Inhibitor, MK-8931, in Patients with Alzheimer’s Disease

Merck, known as MSD outside the United States and Canada, today announced the presentation of results from a Phase Ib study showing a dose-dependent decrease in β amyloid levels in cerebral spinal fluid (CSF) following administration of MK-8931, Merck’s …

Distribution channels: Companies

Published on July 1, 2013 - 21:36 GMT

FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS ...

Monday, July 1, 2013 5:05 pm EDT "As the care of HIV evolves, ISENTRESS continues to be an important treatment option for adult patients with HIV-1" WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United …

Distribution channels: Companies

Published on July 1, 2013 - 13:14 GMT

Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New …

Distribution channels: Companies

Published on July 1, 2013 - 13:13 GMT

Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New …

Distribution channels: Companies

Published on June 28, 2013 - 12:56 GMT

Merck to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2013 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, …

Distribution channels: Companies

Published on June 12, 2013 - 14:10 GMT

Merck Welcomes Independent Review of the Safety Profile of JANUVIA® (sitagliptin) and Other Diabetes Medicines

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today issued the following statement regarding this week's NIDDK-NCI Workshop and the American Diabetes Association’s (ADA) call for an independent …

Distribution channels: Companies

Published on June 2, 2013 - 15:49 GMT

Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in ...

-Merck Expands Lambrolizumab Clinical Development Program- -Study Published Online in the New England Journal of Medicine- Sunday, June 2, 2013 11:15 am EDT "We are very grateful to the patients, investigators, regulators and the broader oncology …

Distribution channels: Companies

Published on June 2, 2013 - 15:25 GMT

Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in ...

-Merck Expands Lambrolizumab Clinical Development Program- -Study Published Online in the New England Journal of Medicine- Sunday, June 2, 2013 11:15 am EDT "We are very grateful to the patients, investigators, regulators and the broader oncology …

Distribution channels: Companies

Published on May 30, 2013 - 13:36 GMT

Merck to Present at the Sanford C. Bernstein Strategic Decisions Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, Merck, is scheduled to present at the Sanford C. Bernstein …

Distribution channels: Companies

Published on May 28, 2013 - 20:28 GMT

Merck Announces Third-Quarter 2013 Dividend

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.43 per share on the company’s common stock for the third quarter of …

Distribution channels: Companies

Published on May 23, 2013 - 22:03 GMT

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck’s investigational adenosine A2A receptor antagonist for the treatment …

Distribution channels: Companies

Published on May 23, 2013 - 22:02 GMT

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck’s investigational adenosine A2A receptor antagonist for the treatment …

Distribution channels: Companies

Published on May 22, 2013 - 23:21 GMT

Merck Statement on FDA Advisory Committee Meeting for Suvorexant

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of …

Distribution channels: Companies

Published on May 22, 2013 - 23:21 GMT

Merck Statement on FDA Advisory Committee Meeting for Suvorexant

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of …

Distribution channels: Companies

Published on May 21, 2013 - 21:33 GMT

Merck Announces $5 Billion Accelerated Share Repurchase

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into an accelerated share repurchase agreement (ASR) with Goldman, Sachs Co. to repurchase $5 billion of …

Distribution channels: Companies

Published on May 17, 2013 - 21:52 GMT

Merck to Present at the UBS Global Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the UBS Global …

Distribution channels: Companies

Published on May 17, 2013 - 13:48 GMT

Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies ...

NEW YORK--(BUSINESS WIRE)--Today, leading global health and development experts from the public and private sectors are joining forces at the 2013 GBCHealth Conference to announce a new partnership that will leverage private sector funding to speed up …

Distribution channels: Companies

Published on May 15, 2013 - 23:15 GMT

Merck Prices $ 6.5 Billion Debt Offering

Wednesday, May 15, 2013 6:29 pm EDT WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Co., Inc. priced today a $6.5 billion public offering of senior unsecured notes. The notes include: $1,000 million of 0.70% notes due May 2016 $500 million of floating …

Distribution channels: Companies

Published on May 14, 2013 - 21:41 GMT

Merck for Mothers Launches Initiative in India to Reduce the Number of Women Dying During Pregnancy and Childbirth

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Merck for Mothers has launched its global initiative for helping reduce maternal mortality in India. It is partnering with three leading non-governmental …

Distribution channels: Companies

Published on May 14, 2013 - 15:11 GMT

Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Frank Clyburn, president, Primary Care and Women's Health, Merck, is scheduled to present at the Bank of America/ …

Distribution channels: Companies

Merck Press Releases Distributed by EIN Presswire